No Data
Affimed Price Target Raised to $25.00/Share From $15.00 by Laidlaw & Co.
Affimed Price Target Raised to $25.00/Share From $15.00 by Laidlaw & Co.
Affimed Is Maintained at Buy by Laidlaw & Co.
Affimed Is Maintained at Buy by Laidlaw & Co.
Truist Financial Maintains Affimed NV(AFMD.US) With Buy Rating
Truist Financial analyst Srikripa Devarakonda maintains $Affimed NV(AFMD.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 48.9% and a total average return of 5.5% o
Laidlaw Initiates Affimed NV(AFMD.US) With Buy Rating, Announces Target Price $25
Laidlaw analyst Yale Jen initiates coverage on $Affimed NV(AFMD.US)$ with a buy rating, and sets the target price at $25.According to TipRanks data, the analyst has a success rate of 29.7% and a total
H.C. Wainwright Maintains Affimed NV(AFMD.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright analyst Swayampakula Ramakanth maintains $Affimed NV(AFMD.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 36
Express News | HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $10 Price Target